Cargando…

MicroRNA-375 plays a dual role in prostate carcinogenesis

BACKGROUND: Prostate cancer (PCa), a highly incident and heterogeneous malignancy, mostly affects men from developed countries. Increased knowledge of the biological mechanisms underlying PCa onset and progression are critical for improved clinical management. MicroRNAs (miRNAs) deregulation is comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa-Pinheiro, Pedro, Ramalho-Carvalho, João, Vieira, Filipa Quintela, Torres-Ferreira, Jorge, Oliveira, Jorge, Gonçalves, Céline S, Costa, Bruno M, Henrique, Rui, Jerónimo, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431534/
https://www.ncbi.nlm.nih.gov/pubmed/25977730
http://dx.doi.org/10.1186/s13148-015-0076-2
_version_ 1782371371789058048
author Costa-Pinheiro, Pedro
Ramalho-Carvalho, João
Vieira, Filipa Quintela
Torres-Ferreira, Jorge
Oliveira, Jorge
Gonçalves, Céline S
Costa, Bruno M
Henrique, Rui
Jerónimo, Carmen
author_facet Costa-Pinheiro, Pedro
Ramalho-Carvalho, João
Vieira, Filipa Quintela
Torres-Ferreira, Jorge
Oliveira, Jorge
Gonçalves, Céline S
Costa, Bruno M
Henrique, Rui
Jerónimo, Carmen
author_sort Costa-Pinheiro, Pedro
collection PubMed
description BACKGROUND: Prostate cancer (PCa), a highly incident and heterogeneous malignancy, mostly affects men from developed countries. Increased knowledge of the biological mechanisms underlying PCa onset and progression are critical for improved clinical management. MicroRNAs (miRNAs) deregulation is common in human cancers, and understanding how it impacts in PCa is of major importance. MiRNAs are mostly downregulated in cancer, although some are overexpressed, playing a critical role in tumor initiation and progression. We aimed to identify miRNAs overexpressed in PCa and subsequently determine its impact in tumorigenesis. RESULTS: MicroRNA expression profiling in primary PCa and morphological normal prostate (MNPT) tissues identified 17 miRNAs significantly overexpressed in PCa. Expression of three miRNAs, not previously associated with PCa, was subsequently assessed in large independent sets of primary tumors, in which miR-182 and miR-375 were validated, but not miR-32. Significantly higher expression levels of miR-375 were depicted in patients with higher Gleason score and more advanced pathological stage, as well as with regional lymph nodes metastases. Forced expression of miR-375 in PC-3 cells, which display the lowest miR-375 levels among PCa cell lines, increased apoptosis and reduced invasion ability and cell viability. Intriguingly, in 22Rv1 cells, which displayed the highest miR-375 expression, knockdown experiments also attenuated the malignant phenotype. Gene ontology analysis implicated miR-375 in several key pathways deregulated in PCa, including cell cycle and cell differentiation. Moreover, CCND2 was identified as putative miR-375 target in PCa, confirmed by luciferase assay. CONCLUSIONS: A dual role for miR-375 in prostate cancer progression is suggested, highlighting the importance of cellular context on microRNA targeting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0076-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4431534
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44315342015-05-15 MicroRNA-375 plays a dual role in prostate carcinogenesis Costa-Pinheiro, Pedro Ramalho-Carvalho, João Vieira, Filipa Quintela Torres-Ferreira, Jorge Oliveira, Jorge Gonçalves, Céline S Costa, Bruno M Henrique, Rui Jerónimo, Carmen Clin Epigenetics Research BACKGROUND: Prostate cancer (PCa), a highly incident and heterogeneous malignancy, mostly affects men from developed countries. Increased knowledge of the biological mechanisms underlying PCa onset and progression are critical for improved clinical management. MicroRNAs (miRNAs) deregulation is common in human cancers, and understanding how it impacts in PCa is of major importance. MiRNAs are mostly downregulated in cancer, although some are overexpressed, playing a critical role in tumor initiation and progression. We aimed to identify miRNAs overexpressed in PCa and subsequently determine its impact in tumorigenesis. RESULTS: MicroRNA expression profiling in primary PCa and morphological normal prostate (MNPT) tissues identified 17 miRNAs significantly overexpressed in PCa. Expression of three miRNAs, not previously associated with PCa, was subsequently assessed in large independent sets of primary tumors, in which miR-182 and miR-375 were validated, but not miR-32. Significantly higher expression levels of miR-375 were depicted in patients with higher Gleason score and more advanced pathological stage, as well as with regional lymph nodes metastases. Forced expression of miR-375 in PC-3 cells, which display the lowest miR-375 levels among PCa cell lines, increased apoptosis and reduced invasion ability and cell viability. Intriguingly, in 22Rv1 cells, which displayed the highest miR-375 expression, knockdown experiments also attenuated the malignant phenotype. Gene ontology analysis implicated miR-375 in several key pathways deregulated in PCa, including cell cycle and cell differentiation. Moreover, CCND2 was identified as putative miR-375 target in PCa, confirmed by luciferase assay. CONCLUSIONS: A dual role for miR-375 in prostate cancer progression is suggested, highlighting the importance of cellular context on microRNA targeting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0076-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-10 /pmc/articles/PMC4431534/ /pubmed/25977730 http://dx.doi.org/10.1186/s13148-015-0076-2 Text en © Costa-Pinheiro et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Costa-Pinheiro, Pedro
Ramalho-Carvalho, João
Vieira, Filipa Quintela
Torres-Ferreira, Jorge
Oliveira, Jorge
Gonçalves, Céline S
Costa, Bruno M
Henrique, Rui
Jerónimo, Carmen
MicroRNA-375 plays a dual role in prostate carcinogenesis
title MicroRNA-375 plays a dual role in prostate carcinogenesis
title_full MicroRNA-375 plays a dual role in prostate carcinogenesis
title_fullStr MicroRNA-375 plays a dual role in prostate carcinogenesis
title_full_unstemmed MicroRNA-375 plays a dual role in prostate carcinogenesis
title_short MicroRNA-375 plays a dual role in prostate carcinogenesis
title_sort microrna-375 plays a dual role in prostate carcinogenesis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431534/
https://www.ncbi.nlm.nih.gov/pubmed/25977730
http://dx.doi.org/10.1186/s13148-015-0076-2
work_keys_str_mv AT costapinheiropedro microrna375playsadualroleinprostatecarcinogenesis
AT ramalhocarvalhojoao microrna375playsadualroleinprostatecarcinogenesis
AT vieirafilipaquintela microrna375playsadualroleinprostatecarcinogenesis
AT torresferreirajorge microrna375playsadualroleinprostatecarcinogenesis
AT oliveirajorge microrna375playsadualroleinprostatecarcinogenesis
AT goncalvescelines microrna375playsadualroleinprostatecarcinogenesis
AT costabrunom microrna375playsadualroleinprostatecarcinogenesis
AT henriquerui microrna375playsadualroleinprostatecarcinogenesis
AT jeronimocarmen microrna375playsadualroleinprostatecarcinogenesis